Literature DB >> 34105998

HMGB1 Knockout Decreases Kaposi's Sarcoma-Associated Herpesvirus Virion Production in iSLK BAC16 Cells by Attenuating Viral Gene Expression.

Su-Kyung Kang1, Yun Hee Kang2, Seung-Min Yoo1, Changhoon Park1, Hong Seok Kim3, Myung-Shin Lee1,2.   

Abstract

Multiple host proteins affect the gene expression of Kaposi's sarcoma-associated herpesvirus (KSHV) during latent and lytic replication. High-mobility group box 1 (HMGB1) serves as a highly conserved chromosomal protein inside the cell and a prototypical damage-associated molecular pattern molecule outside the cell. HMGB1 has been shown to play a pathogenic role in viral infectious diseases and to regulate the lytic replication of KSHV. However, its functional effects on the KSHV life cycle in KSHV-infected cells have not been fully elucidated. Here, we explored the role of intracellular and extracellular HMGB1 in KSHV virion production by employing CRISPR/Cas9-mediated HMGB1 knockout in the KSHV-producing iSLK BAC16 cell line. Intracellular HMGB1 formed complexes with various proteins, and the abundance of HMGB1-interacting proteins changed during latent and lytic replication. Moreover, extracellular HMGB1 was found to enhance lytic replication by phosphorylating JNK. Of note, the expression of viral genes was attenuated during lytic replication in HMGB1 knockout iSLK BAC16 cells, with significantly decreased production of infectious virions compared to that of wild-type cells. Collectively, our results demonstrate that HMGB1 is an important cellular cofactor that affects the generation of infectious KSHV progeny during lytic replication. IMPORTANCE The high-mobility group box 1 (HMGB1) protein has many intra- and extracellular biological functions with an intricate role in various diseases. In certain viral infections, HMGB1 affects the viral life cycle and pathogenesis. In this study, we explored the effects of HMGB1 knockout on the production of Kaposi's sarcoma-associated herpesvirus (KSHV). HMGB1 knockout decreased virion production in KSHV-producing cells by decreasing the expression of viral genes. The processes by which HMGB1 affects KSHV production may occur inside or outside infected cells. For instance, several cellular and viral proteins interacted with intracellular HMGB1 in a nucleosomal complex, whereas extracellular HMGB1 induced JNK phosphorylation, thereby enhancing lytic replication. Our results suggest that both intracellular and extracellular HMGB1 are necessary for efficient KSHV replication. Thus, HMGB1 may represent an effective therapeutic target for the regulation of KSHV production.

Entities:  

Keywords:  CRISPR/Cas9; HMGB1; JNK signaling; KSHV; gene expression; herpesvirus; virus production

Mesh:

Substances:

Year:  2021        PMID: 34105998      PMCID: PMC8312881          DOI: 10.1128/JVI.00799-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.

Authors:  Jianping Xie; Adetola Olalekan Ajibade; Fengchun Ye; Kurt Kuhne; Shou-Jiang Gao
Journal:  Virology       Date:  2007-10-26       Impact factor: 3.616

2.  Kaposi's sarcoma-associated herpesvirus (KSHV) Rta and cellular HMGB1 proteins synergistically transactivate the KSHV ORF50 promoter.

Authors:  Sally M Harrison; Adrian Whitehouse
Journal:  FEBS Lett       Date:  2008-08-08       Impact factor: 4.124

3.  Guanylate-Binding Protein 1 Inhibits Nuclear Delivery of Kaposi's Sarcoma-Associated Herpesvirus Virions by Disrupting Formation of Actin Filament.

Authors:  Zhe Zou; Zhihua Meng; Chao Ma; Deguang Liang; Rui Sun; Ke Lan
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

4.  Critical role of RAGE and HMGB1 in inflammatory heart disease.

Authors:  Anna Bangert; Martin Andrassy; Anna-Maria Müller; Mariella Bockstahler; Andrea Fischer; Christian H Volz; Christoph Leib; Stefan Göser; Sevil Korkmaz-Icöz; Stefan Zittrich; Andreas Jungmann; Felix Lasitschka; Gabriele Pfitzer; Oliver J Müller; Hugo A Katus; Ziya Kaya
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-29       Impact factor: 11.205

5.  Raf/MEK/ERK signalling triggers reactivation of Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Patrick W Ford; Benjaman A Bryan; Ossie F Dyson; Douglas A Weidner; Vishnu Chintalgattu; Shaw M Akula
Journal:  J Gen Virol       Date:  2006-05       Impact factor: 3.891

6.  The ORF45 protein of Kaposi's sarcoma-associated herpesvirus is associated with purified virions.

Authors:  Fan Xiu Zhu; Yan Yuan
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 7.  Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?

Authors:  Ulf Andersson; William Ottestad; Kevin J Tracey
Journal:  Mol Med       Date:  2020-05-07       Impact factor: 6.354

8.  NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA.

Authors:  Fang Zhang; Deguang Liang; Xiaoxi Lin; Zhe Zou; Rui Sun; Xing Wang; Xiaozhen Liang; Kenneth M Kaye; Ke Lan
Journal:  PLoS Pathog       Date:  2019-02-27       Impact factor: 6.823

9.  HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talk.

Authors:  Héla Saïdi; Marie-Thérèse Melki; Marie-Lise Gougeon
Journal:  PLoS One       Date:  2008-10-31       Impact factor: 3.240

10.  miRNA-1284, a regulator of HMGB1, inhibits cell proliferation and migration in osteosarcoma.

Authors:  Shuai Lv; Meng Guan
Journal:  Biosci Rep       Date:  2018-07-12       Impact factor: 3.840

View more
  2 in total

1.  Dimethyl Sulfoxide Enhances Kaposi's Sarcoma-Associated Herpesvirus Production During Lytic Replication.

Authors:  Su-Kyung Kang; Myung-Ju Lee; Ho-Hyun Ryu; Jisu Lee; Myung-Shin Lee
Journal:  Front Microbiol       Date:  2021-12-16       Impact factor: 5.640

2.  Alpha-2-macroglobulin as a novel diagnostic biomarker for human bladder cancer in urinary extracellular vesicles.

Authors:  Jisu Lee; Hyun Sik Park; Seung Ro Han; Yun Hee Kang; Ji Young Mun; Dong Wook Shin; Hyun-Woo Oh; Yoon-Kyoung Cho; Myung-Shin Lee; Jinsung Park
Journal:  Front Oncol       Date:  2022-09-13       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.